This study aims to quantify the MT and CEST parameters in glioblastoma at 1.5T over four time points of chemoradiation. Previous approaches to quantify the MT/CEST signal in terms of response to treatment were at higher field strengths. Additionally, we analyzed different subregions within the clinical target volume and gross tumor volume, generated by thresholding based on the T1-weighted, FLAIR and DWI scans, for comparing the MT/CEST parameters between the early and late tumor progression. Results indicated that MT/CEST at 1.5T can be used for monitoring therapy and that the results depend on the specific tumor region analyzed.
This abstract and the presentation materials are available to members only; a login is required.